A recent study indicates that patients who stop using popular slimming jabs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end traditional lifestyle plans.
Research printed in a major medical journal demonstrates that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users using such treatments should be informed of the potential of rapid rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass within about 18 months.
Analyzing Treatments
The research, which reviewed dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with conventional dieting.
The team note that individuals who shed pounds through diet and exercise usually have a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Experts suggest the mechanism of the jabs accounts for the amplified rebound.
These medications mimic a natural hormone called GLP-1, which controls appetite.
"Long-term administration of the hormone concentrations several times higher than normal may cause the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication results in hunger is uncontrolled, making overeating much more probable."
An Ongoing Disease?
Medical guidelines advise the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians argue that, given the likelihood of weight regain, the treatment might need to be life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "emphasize the chronic character of obesity," akin to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have come off the jabs describe a powerful resurgence of appetite.
"It was like something flipping and you become ravenous," recalled a patient.
The struggle is worsened if users have not established permanent lifestyle or habit modifications during therapy.
Widespread Interest
Figures suggest that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.
- Adoption is more common among women than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits relies on integrated behavioural management.
